Mean High-Dose l-Thyroxine Treatment Is Efficient and Safe to Achieve a Normal IQ in Young Adult Patients With Congenital Hypothyroidism
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Context: The optimal levothyroxine (LT4) dose to treat congenital hypothyroidism (CH) remains unclear, with debate over whether higher starting doses (>10 µg/kg) are necessary and safe for a normal intelligence quotient (IQ). Objective: To examine psychomotor, metabolic, and quality of life (QoL) outcomes in patients with CH treated with a mean high initial LT4 dose. Design, settings, participants: A cross-sectional cohort study of patients with CH identified in the Berlin newborn screening program from 1979 to 2003; 76 patients with CH (mean age, 18 years; mean initial LT4 dose, 13.5 µg/kg) and 40 siblings completed the study. Main outcome measures: Psychomotor (Wechsler Intelligence Test, CNS Vital Signs), QoL (short form-36 Health Survey), anthropometric (body mass index, height), and metabolic (intima media thickness, laboratory parameters) outcomes were compared with those of healthy siblings. Mean values and percentage of episodes of elevated thyroxine (T4) and tri-jod-thyronin (T3) and suppressed thyrotropin (TSH) before age 2 years were analyzed. A meta-analysis of CH treatment studies was performed. Results: There were no significant differences in IQ, QoL, or other outcome measures in patients with CH compared with controls. Most T4 levels were high before age 2 years and during subsequent testing, but mean T3 and TSH levels remained normal. The meta-analysis showed a significant IQ difference in severe vs mild CH cases only when treatment started with an LT4 dose <10 µg/kg. Conclusions: High initial LT4 dosing was effective and safely achieved optimal cognitive development in patients with CH, including those severely affected. Supranormal T4 values during infancy were not associated with impaired IQ in adolescence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The treatment approach resembled the New Zealand approach with a median age at diagnosis of 8 days, a mean LT4 starting dose of 13.5 μg/kg per day, and TSH normalizing within a median time of 15 days.”
From Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology (2021) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the New Zealand and the Berlin studies, treatment effectiveness in terms of normalization of serum parameters was tested weekly after the start of treatment until they normalized (90,91).”
From Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology (2021) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even in the children with the highest number of episodes of TSH suppression, IQ and other outcome parameters did not differ.”
From Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology (2021) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Body mass index and composition are generally normal in children and adult with CH (90,91,187), and comparable with that of the general population.”
From Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology (2021) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since the thyroid hormone levels are higher during childhood, higher doses of LT4 are required in children (56).”
From The diagnosis and management of central hypothyroidism in 2018 (2019) · cites this paper as [56]
Experimental — accuracy not yet measured
16 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569
Self-citationMutations in SECISBP2 result in abnormal thyroid hormone metabolism
Dumitrescu, A. M., Liao, X.-H., Abdullah, M. S. Y., Lado-Abeal, J., Majed, F. A., Moeller, L. C., Boran, G., Schomburg, L., Weiss, R. E., & Refetoff, S. (2005) · Nature Genetics · doi:10.1038/ng1654 · Cited by 412
Congenital Hyperthyroidism Caused by a Mutation in the Thyrotropin-Receptor Gene
Kopp, P., van Sande, J., Parma, J., Duprez, L., Gerber, H., Joss, E., Jameson, J. L., Dumont, J. E., & Vassart, G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501193320304 · Cited by 315
Triiodothyronine Levels in Athyreotic Individuals During Levothyroxine Therapy
Jonklaas, J. (2008) · JAMA · doi:10.1001/jama.299.7.769 · Cited by 216
Dubuis, J. M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.222 · Cited by 194
Oerbeck, B., Sundet, K., Kase, B. F., & Heyerdahl, S. (2003) · Pediatrics · doi:10.1542/peds.112.4.923 · Cited by 176
Wechsler Intelligenztest für Erwachsene (WIE).
Jacobs, C., & Petermann, F. (2007) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747.55.3.205 · Cited by 167
Salerno, M., Militerni, R., Bravaccio, C., Micillo, M., Capalbo, D., Di Maio, S., & Tenore, A. (2002) · Thyroid · doi:10.1089/105072502753451968 · Cited by 165
SUCCESSFUL LABORATORY SCREENING FOR CONGENITAL HYPOTHYROIDISM
Klein, A. H., Agustin, A. V., & Tp, F. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91637-7 · Cited by 151
Long-term effects of L-thyroxine therapy for congenital hypothyroidism
ROVET, J. F., & Ehrlich, R. M. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70452-3 · Cited by 136
Research works printed but not linked: 4
- Osler W. Sporadic cretinism in America. In: Transactions of the Congress of American Physicians and Surgeons, Fourth Triennial Session; May 4-5, 1897; Washington, DC; 169-206.
- Wechsler D, Petermann F, Petermann U. WISC-IV Wechsler In- telligence Scale for Children. 4th ed. Frankfurt, Germany: Pearson Assessment & Information GmbH; 2011.
- Morfeld M, Kirchberger I, Bullinger M. SF-36 Fragebogen zum Gesundheitszustand Manual. 2nd ed. G öttingen, Germany: Hog- refe Verlag; 2011.
- Oberw öhrmann S, Bettge S. Gesundheitsberichterstattung Berlin Spezialbericht Grundauswertung der Einschulungsdaten 2006 zur Gesundheitlichen und Sozialen Lage von Kindern in Berlin. Berlin, Germany: Senatsverwaltung f ür Gesundheit, Umwelt und Ver- braucherschutz; 2008.
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“The second study reporting no gap comparing 76 CH patients and 40 sibling controls was from Berlin and was published in 2018 (91).”
BackgroundResultInfluentialSelf-citationPersani, L., Brabant, G., Dattani, M., Bonomi, M., Feldt-Rasmussen, U., Fliers, E., Gruters, A., Maiter, D., Schoenmakers, N., & van Trotsenburg, A. S. P. (2018) · European Thyroid Journal · doi:10.1159/000491388 · Cited by 222
Self-citationCongenital Hypothyroidism: Screening and Management
Rose, S. R., Wassner, A. J., Wintergerst, K. A., Jones, N. Y., Hopkin, R. J., Chuang, J., Smith, J. R., Abell, K. B., LAFRANCHI, S. H., Wintergerst, K. A., et al. (2022) · PEDIATRICS · doi:10.1542/peds.2022-060420 · Cited by 129
Congenital Hypothyroidism: Screening and Management
Rose, S. R., Wassner, A. J., Wintergerst, K. A., Jones, N. Y., Hopkin, R. J., Chuang, J., Smith, J. R., Abell, K. B., LAFRANCHI, S. H., Wintergerst, K. A., et al. (2022) · PEDIATRICS · doi:10.1542/peds.2022-060419 · Cited by 132
Diagnosis and Management of Central Congenital Hypothyroidism
Lauffer, P., Zwaveling‐Soonawala, N., Naafs, J. C., Boelen, A., & van Trotsenburg, A. S. P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.686317 · Cited by 89
“In contrast, the latest long-term follow-up studies in patients with primary CH show that when LT4 treatment is started before the (mean) age of 10 days with a starting dose of at least 10 mg/kg per day, affected children have a neurodevelopmental outcome similar to that of unaffected siblings in the second decade of…”
BackgroundThe diagnosis and management of central hypothyroidism in 2018
Persani, L., Cangiano, B., & Bonomi, M. (2019) · Endocrine Connections · doi:10.1530/ec-18-0515 · Cited by 64
Update on congenital hypothyroidism
Cherella, C. E., & Wassner, A. J. (2020) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000520 · Cited by 61
Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism
Bauer, A. J., & Wassner, A. J. (2019) · Endocrine · doi:10.1007/s12020-019-02024-6 · Cited by 67
Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision)
Nagasaki, K., Minamitani, K., Nakamura, A., Kobayashi, H., Numakura, C., Itoh, M., Mushimoto, Y., Fujikura, K., Fukushi, M., & Tajima, T. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0063 · Cited by 48
Esposito, A., Vigone, M. C., Polizzi, M., Wasniewska, M. G., Cassio, A., Mussa, A., Gastaldi, R., Mase, R. D., Vincenzi, G., Pozzi, C., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.923448 · Cited by 39
“and young adults with CH (4) even compared with sibling controls (12, 24).”
BackgroundWhite matter microstructural abnormalities in children with severe congenital hypothyroidism
Cooper, H. E., Kaden, E., Halliday, L. F., Bamiou, D., Mankad, K., Peters, C. J., & Clark, C. A. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101980 · Cited by 31
Naafs, J. C., Heinen, C. A., Zwaveling-Soonawala, N., van der Schoor, S. R. D., van Tellingen, V., Heijboer, A. C., Fliers, E., Boelen, A., & van Trotsenburg, A. S. P. (2020) · Thyroid® · doi:10.1089/thy.2019.0779 · Cited by 21
Naafs, J. C., Marchal, J. P., Fliers, E., Verkerk, P. H., Luijten, M. A. J., Boelen, A., van Trotsenburg, A. S. P., & Zwaveling-Soonawala, N. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa901 · Cited by 21
“Apgar score <6 at 5 minutes of age 5 (6) 1 (2)”
BackgroundInfluentialDesarrollo social, cognitivo y psicomotor en niños peruanos con hipotiroidismo congénito
Herrera-Chinchay, L., Silva-Ocas, I., Castro-Silva, N., & Villar, C. D. Á. (2021) · Andes pediatrica · doi:10.32641/andespediatr.v92i2.1955 · Cited by 25
Stagi, S., Municchi, G., Ferrari, M., & Wasniewska, M. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.859487 · Cited by 20
“, which showed that a high initial l-T4 dose of between 10 and 15 mg/kg/day was effective and safe in all CH patients and that high FT4 values during infancy did not correlate with IQ impairment at adolescence (18).”
BackgroundTarget diseases for neonatal screening in Germany—challenges for treatment and long-term care
Spiekerkoetter, U., & Krude, H. (2022) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2022.0075 · Cited by 22
Self-citationDisorders of the Thyroid Gland
Styne, D. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-09512-2_6 · Cited by 14
Krude, H., Biebermann, H., Schuelke, M., Müller, T. D., & Tschöp, M. H. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1108-1456 · Cited by 13
Self-citationThe Consensus on the Diagnosis and Management of Congenital Hypothyroidism in Term Neonates
Hashemipour, M., Rabbani, A., Rad, A. H., & Dalili, S. (2023) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_535_21 · Cited by 12
“For congenital hypothyroidism, it is better to start treatment based on FT4 because general therapy of 10–15 μg/Kg sometimes causes hyperthyroidism.[17,24,25] Treatment based on FT4 is summarized in Table 2.”
BackgroundWilpert, N., Thamm, R., Thamm, M., Kratzsch, J., Seelow, D., Vogel, M., Krude, H., & Schuelke, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168585 · Cited by 11
“If detected early enough through newborn screening and treated with high doses of thyroid hormone, these newborns have a normal neurodevelopmental and somatic outcome [2].”
BackgroundSelf-citationLipska, E., Lecka-Ambroziak, A., Witkowski, D., Szamotulska, K., Mierzejewska, E., & Ołtarzewski, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.895507 · Cited by 11
“, including 438 patients, the authors pointed out that the recommended L-T4 dosage is safe and efficient, and lower doses can lead to 6-8 points lower IQ in children with severe CH (21).”
BackgroundComorbidity in Congenital Hypothyroidism—A Nationwide, Population-based Cohort Study
Danner, E., Jääskeläinen, J., Niuro, L., Huopio, H., Niinikoski, H., Viikari, L. A., Kero, J. T., & Sund, R. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad334 · Cited by 13
Vidavalur, R. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.788589 · Cited by 12
Cheetham, T. D., & Wood, C. L. (2024) · Clinical Endocrinology · doi:10.1111/cen.15110 · Cited by 11
“35 Key variables to consider include the severity of the underlying CHT, time to initial treatment, dose of T4 required and frequency of monitoring.”
GWAS of thyroid dysgenesis identifies a risk locus at 2q33.3 linked to regulation of Wnt signaling
Narumi, S., Opitz, R., Nagasaki, K., Muroya, K., Asakura, Y., Adachi, M., Abe, K., Sugisawa, C., Kühnen, P., Ishii, T., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac093 · Cited by 9
Self-citationde Andrade, J. E., Dias, V. M. A., de Paula, J. J., & Silva, I. N. (2021) · Child Neuropsychology · doi:10.1080/09297049.2021.1876010 · Cited by 9
“Different factors associated with thyroid disease, such as CH etiology, initial levothyroxine dose and age at the beginning of treatment (Aleksander et al., 2018; Dimitropoulos et al., 2009; Rahmani et al., 2016) have been linked to cognitive difficulties.”
BackgroundDisorders of the Thyroid in the Newborn and Infant
Deladoëy, J., Oettingen, J. E. V., & Vliet, G. V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00008-7 · Cited by 8
Danner, E., Niuro, L., Lapinoja, S., Huopio, H., Viikari, L. A., Kero, J. T., Jääskeläinen, J., & Niinikoski, H. (2024) · Acta Paediatrica · doi:10.1111/apa.17479 · Cited by 7
Dépistage de l’hypothyroïdie congénitale
Léger, J. (2021) · médecine/sciences · doi:10.1051/medsci/2021058 · Cited by 9
Cognitive outcome of 458 children over 25 years of neonatal screening for congenital hypothyroidism
Pelaez, J. M., RAMOS, J. C. R. R., Domingos, M. T., de Lima, M. R., Kraemer, G., Cardoso-Demartini, A. D. A., Pereira, R. M., de Lacerda, L., & Nesi-França, S. (2023) · Jornal de Pediatria · doi:10.1016/j.jped.2023.03.003 · Cited by 6
“482 It has been demonstrated that an earlier start of treatment combined with a high l-T4 dose, especially in more severe cases, contributes to better cognitive outcomes, and a normal FSIQ, that does not differ from unaffected siblings, may be achieved.(3,4,23) In the present sample, age at start of treatment was a de…”
BackgroundProspective study of thyroid function in the first year of life in infants with Down syndrome
Feldman, P. M., Rodríguez, N., Morrison, E., BARTON, B. A., & Lee, M. M. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-04954-w · Cited by 7
“It is our practice to treat all infants with SH (normal FT4 with TSH above the age-specific reference interval) with a low dose of levothyroxine to maintain euthyroidism and to avoid overtreatment (moreover, studies show conflicting results on neurodevelopmental outcomes in infants with CH who were overtreated [25, 26…”
ResultStoupa, A., Kariyawasam, D., Jabot‐Hanin, F., Quoc, A. N., Hanein, S., Rabeony, T., Elie, C., Colas, S., Thalassinos, C., Petit, I., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf004 · Cited by 5
Gunnerbeck, A., Lundholm, C., von Döbeln, U., Zetterström, R. H., Almqvist, C., & Nordenström, A. (2024) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2024.114240 · Cited by 4
Koch, G., Steffens, B., Leroux, S., Gotta, V., Schropp, J., Gaechter, P., Bachmann, F., Welzel, T., Janner, M., l’Allemand, D., et al. (2021) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-021-09765-w · Cited by 4
Newborn Screening in Pediatric Endocrine Disorders
Draznin, M. B., Borgohain, P., & Kanungo, S. (2022) · Endocrines · doi:10.3390/endocrines3010010 · Cited by 4
“Among advances in identifying and treating CH are more rapid normalization of thyroid status with an increase in initial thyroxine dose from 8–10 mcg/kg to 10–15 mcg/kg [16,17] and the ability to identify infants with the rare genetically inherited forms earlier.”
BackgroundBüyükavcı, M. A., & Dündar, İ. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0539 · Cited by 4
Knowns and unknowns about congenital hypothyroidism: 2022 update
Itonaga, T., Hasegawa, Y., Higuchi, S., Satoh, M., Sawada, H., Shimura, K., Takahashi, I., Takubo, N., & Nagasaki, K. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0016 · Cited by 7
“However, Aleksander et al. (14) showed no difference in IQ between patients and their siblings, despite a similar duration of overtreatment.”
InfluentialTransitional Care in Endocrinology
Dwyer, A. A., & Hauschild, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-23384-6_12 · Cited by 3
Thomann, J., Tittel, S. R., Voß, E., Oeverink, R., Palm, K., Fricke‐Otto, S., Kapelari, K., Holl, R. W., Woelfle, J., & Bettendorf, M. (2021) · International Journal of Neonatal Screening · doi:10.3390/ijns7010010 · Cited by 3
“Thus, the basic preconditions for achieving the best possible patient outcome with adequate therapy were given in both cohorts [25-27].”
BackgroundAdult and neonate TSH blood spot reference intervals
Morris, T., Layley, J., Geevarghese, R., Steele, L., Ssali, J., & Mirzazadeh, M. (2022) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632221112654 · Cited by 2
“The identification and timely treatment of CHT mitigates the intellectual disability that can otherwise be caused by the disorder.(8) Acquired primary hypothyroidism is a common disorder that increases in prevalence with age, especially after the middle-age period, and occurs more frequently in women than men.”
BackgroundVincenzi, G., Tarantola, G., Mora, S., Abbate, M. T. A., Santagiuliana, C., Petralia, I. T., Giacco, L. D., Zanelli, S., Barera, G., & Vigone, M. C. (2025) · Endocrine · doi:10.1007/s12020-025-04230-x · Cited by 2
Djermane, A., Ouarezki, Y., Boulesnane, K., Kherra, S., Bouferoua, F., Bessahraoui, M., Selim, N., Djahlat, L., Mohammedi, K., Nedjadi, K. B., et al. (2025) · International Journal of Neonatal Screening · doi:10.3390/ijns11030078 · Cited by 4
“The standard treatment for CH involves L-T 4 replacement therapy, typically initiated at a dose of 10–15 mcg/kg/day [57,59,60].”
Endocrine components of newborn screening
Russell, M. (2020) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2020.100772 · Cited by 2
Shreder, E. V., Shiryaeva, T., Nagaeva, E. V., & Bezlepkina, O. B. (2021) · Clinical and experimental thyroidology · doi:10.14341/ket12703 · Cited by 3
RAMOS, J. C. R. R., Pelaez, J. M., Ono, S. E., Ramos, C. S., Neto, A. D. C., de Lacerda, L., & Nesi-França, S. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad391 · Cited by 2
Angeborene Schilddrüsenerkrankungen bei Neugeborenen und Kleinkindern
Krude, H., & Grüters‐Kieslich, A. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-57309-9_31 · Cited by 2
Self-citationPersani, L., Brabant, G. E., Dattani, M., Bonomi, M., Feldt‐Rasmussen, U., Fliers, E., Grüters, A., Maiter, D. M., Schoenmakers, N. A., & van Trotsenburg, A. S. P. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.3.16 · Cited by 1
Self-citationFetal and Postnatal Disorders of Thyroid Function
Lawrence, S. E., Oettingen, J. E. V., & Deladoëy, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00044-1 · Cited by 2
Follow-up study of preterm infants with thyroid dysfunction after medication.
Li, F.-C., Duan, J.-Y., Zhang, Y.-H., Han, S., Ma, X., Cai, S.-Y., & Li, L. (2021) · PubMed · doi:10.7499/j.issn.1008-8830.2108006 · Cited by 1
“[25] Aleksander PE, Brückner-Spieler M, Stoehr AM, et al.”
Congenital Hypothyroidism: Screening, Early Management, and Outcome
Cheetham, T. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65359-x · Cited by 1
Aleksander, P. (2020) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-26701
Self-citationМетоды хирургического лечения многоузлового зоба у пациентов в йододефицитном регионе
Магомедов, М. М., & Османов, О. М. (2021) · Естественные и Технические Науки · doi:10.37882/2223-2966.2021.02.16
Angeborene Schilddrüsenerkrankungen bei Neugeborenen und Kleinkindern
Krude, H., & Grüters‐Kieslich, A. (2018) · Springer Reference Medizin · doi:10.1007/978-3-662-52794-8_31-1 · Cited by 1
Self-citationSaran, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81129 · Cited by 3
“Low IQ in infants with T4 concentration below 10 μgm/dl and TSH above 15 μU/dl was seen during the first year of life compared to those had serum T4 more than 10 μgm/dl [50].”
BackgroundCongenital Hypothyroidism: A Historical Perspective on Cognitive Outcome
Krude, H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66199-8
Self-citationAngeborene und erworbene Hypothyreose: Wie interpretiere ich Schilddrüsenwerte richtig?
Gesing, J. K., Stoltze, A., Göpel, E., Pfäffle, R. W., & Kieß, W. (2023) · Kinder- und Jugendmedizin · doi:10.1055/a-1991-3455
“J Clin Endocrinol Metab 2013; 98: 3663–3670 [8] Aleksander PE, Bruckner-Spieler M, Stoehr AM et al.”
BackgroundSignorino, C., Municchi, G., Ferrari, M., & Stagi, S. (2023) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2023.2023-9-12
“High starting doses of L-T4, between 10 and 15 mg/kg are the treatment of choice and determine both auxological (3) and neurological improvement (4).”
Perros, P. (2024) · Copernicus books · doi:10.1007/978-3-031-58287-5_7
Neonatal Screenings for Congenital Hypothyroidism
Orman, B., & Çetinkaya, S. Ç. (2024) · doi:10.69860/nobel.9786053358961.2
Congenital hypothyroidism: Screening, early management and outcome
Cheetham, T. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00241-7
Permanent Congenital Hypothyroidism in Very Low Birth Weight Infants: A Single Center’s Experience
Roh, J. H., Kim, T.-G., Seol, K. H., Kim, C. Y., Kim, S. H., Jeong, J., Kim, J. H., Jung, E., Choi, J., & Lee, B. S. (2025) · Neonatal Medicine · doi:10.5385/nm.2025.32.1.30
“To reduce the risk of NDI, many centers continue to maintain LT4 therapy until 36 months of age, which may lead to overtreatment in infants with TCH. Previous studies have also suggested that the longitudinal LT4 dosage requirement may help predict PCH, and some have proposed an earlier trial-off therapy at or before…”
Improving Clinical Care for Children with Congenital Hypothyroidism
Bakjaji, S., Anglin, K., Clotts, T., Dorsten, B., Jones, K., Young, C., Zoofan, S., Abdel-Hadi, M., Damilano, C. P., & Obrynba, K. S. (2025) · Pediatric Quality and Safety · doi:10.1097/pq9.0000000000000844
“Our QI project aligns with existing literature on the importance of timely diagnosis and treatment of CH. 16, 18 However, even when treatment is”
Cognitive outcome of congenital hypothyroidism
Krude, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00366-6
Self-citationÇetiner, E. B., & Singin, B. (2026) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2026.2026-1-15
“In term infants, the recommended initial dose is 10-15 µg/kg/day, a range that has been associated with optimal neurocognitive outcomes, normal growth, and improved school performance (10,11).”
Salerno, M., Vigone, M. C., Cassio, A., Cavarzere, P., Cherubini, V., Faienza, M. F., Gastaldi, R., Tuli, G., Wasniewska, M. G., & Olivieri, A. (2026) · Endocrine · doi:10.1007/s12020-026-04656-x
“Notably, patients with severe CH reached similar results to those with milder forms only when treated with an initial dose exceeding 10 µg/kg/day [95].”
Influential
Metadata
- Authors
- Aleksander, P. E., Brückner-Spieler, M., Stoehr, A.-M., Lankes, E., Kühnen, P., Schnabel, D., Ernert, A., Stäblein, W., Craig, M. E., Blankenstein, O., Grüters, A., & Krude, H.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Institute for Experimental Pediatric Endocrinology, Charité Universitätsmedizin Berlin, Berlin, Germany
- Children's Hospital at Westmead (AU)
- Heidelberg University (DE)
- Corresponding author
- Krude, Heiko
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-01-09
- Volume
- 103
- Issue
- 4
- Pages
- 1459-1469
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2782759999
- Cited by
- 64
- References
- 36
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 12 · 2021: 11 · 2020: 5 · 2019: 9 · 2018: 4
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- congenital hypothyroidism, levothyroxine, intelligence quotient, cognitive development, quality of life, psychomotor outcomes, thyroxine, triiodothyronine, thyroid-stimulating hormone, intima-media thickness, body mass index, newborn screening, adolescents, siblings
- MeSH terms
- Adolescent, Congenital Hypothyroidism, Cross-Sectional Studies, Female, Humans, Infant, Newborn, Intelligence, Male, Quality of Life, Thyroxine, Triiodothyronine, Wechsler Scales, Body Mass Index, Neonatal Screening, Young Adult, Carotid Intima-Media Thickness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.